Back to discover
Disease
Gallbladder Neoplasms
Late-stage therapeutic developmentEmerging research
2
Publications
7
Clinical trials
2023
Latest publication
Latest activity
betaRecent clinical, regulatory, research and industry developments relating to this disease.
NCCN Guidelines® Insights: Biliary Tract Cancers, Version 2.2023.
Research2023-07-01Journal of the National Comprehensive Cancer Network : JNCCN
Overview of current targeted therapy in gallbladder cancer.
Research2020-10-07Signal transduction and targeted therapy
What's happening now
An analyst briefing on current research, clinical, regulatory and industry activity surrounding this disease.
Executive briefingUpdating summary…Momentum: Low
Key developments
- 1 clinical trial expected to report results, the earliest in Q4 2029.
Major developments
Upcoming trial readoutImportant
Results expected Q4 20292025-12-02
Major clinical milestoneImportant
Primary completion2026-07-01
Clinical MilestonesViewHide
Recently completed
Activity timeline2
- 2026-07-01ClinicalPhase II Basket Study to Evaluate the Tissue-agnostic Efficacy of Anti-Programmed Cell Death Protein 1 (Anti-PD1) Monoclonal Antibody in Patients With Advanced Rare TumorsPrimary completion
- 2025-12-02ClinicalDETERMINE (Determining Extended Therapeutic Indications for Existing Drugs in Rare Molecularly Defined Indications Using a National Evaluation Platform Trial): An Umbrella-Basket Platform Trial to Evaluate the Efficacy of Targeted Therapies in Rare Adult, Paediatric and Teenage/Young Adult (TYA) Cancers With Actionable Genomic Alterations, Including Common Cancers With Rare Actionable Alterations. Treatment Arm 04: Trastuzumab in Combination With Pertuzumab in Adult, Paediatric and Teenage/Young Adult Patients With Cancers With HER2 Amplification or Activating Mutations.Results expected Q4 2029
Clinical trials
The current development programme across all trial phases.
Clinical programme
7
2
3
4
Late-stage studies
Recruiting
Recently completed
Research activity
Key research shaping understanding of this disease, combining the latest publications with the most influential evidence.
Publications over time
20202023
Most influential
Major themes6
- Gallbladder Neoplasms2
- Bile Duct Neoplasms1
- Biliary Tract Neoplasms1
- Cholangiocarcinoma1
- Liver Neoplasms1
- Precision Medicine1
Leading journals2
- Journal of the National Comprehensive Cancer Network : JNCCN1
- Signal transduction and targeted therapy1
Leading researchers8
- Abbott DE1
- Abrams T1
- Ahmed A1
- Anaya DA1
- Anders R1
- Are C1
- Bachini M1
- Benson AB1
Affiliations (unnormalised)6
- Abramson Cancer Center at the University of Pennsylvania.1
- Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute.1
- City of Hope National Medical Center.1
- Dana-Farber/Brigham and Women's Cancer Center.1
- Department of General Surgery and Laboratory of General Surgery1
- Duke Cancer Institute.1
Reference
Authoritative identity, definition & identifiers.
Defined in MeSH
Tumors or cancer of the gallbladder.
Identifiers
References & data sources
- Disease identity & definition — NLM Medical Subject Headings (MeSH), public domain
- Clinical trials — ClinicalTrials.gov (U.S. National Library of Medicine)
- Research activity — Europe PMC (EMBL-EBI) + OpenAlex-derived paper links
- Related entities are derived from literature co-mention (studied together) — associative, not causal.